SUTRO BIOPHARMA, INC.

EDGAR

Market value

$159.04M

16,601,411 shares as of 2026-11-06, at $9.58 a share (STRO, IEX close on 2026-11-12) Primary-source evidence

Annual consolidated revenue for 2025: about USD 102.5M, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2024, was about USD 62.04M.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-09-18 Gerber Hans-Peter M 3,750 0
  • 2026-09-18 Gerber Hans-Peter F 1,345 15.34
  • 2026-09-18 Gerber Hans-Peter M 3,750 0
  • 2026-06-05 Jagpal Sukhi A 10,000 0
  • 2026-06-05 Dybbs Michael A 10,000 0

5% holders (Schedule 13D and 13G)

  • Coastlands Capital LP 5.14% SCHEDULE 13G 11/05/2026
  • Coastlands Capital Partners LP 5.14% SCHEDULE 13G 11/05/2026
  • Coastlands Capital GP LLC 5.14% SCHEDULE 13G 11/05/2026

Institutional holders (Form 13F)

  • BVF INC/IL 1,251,788 SH
  • BlackRock, Inc. 1,178,196 SH
  • Affinity Asset Advisors, LLC 1,152,487 SH
  • SAMSARA BIOCAPITAL, LLC 1,062,872 SH
  • PERCEPTIVE ADVISORS LLC 970,846 SH

Trades by members of Congress

See all insider transactions

Latest quarter

Revenue

9.1 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating margin

-241.33%

2026 Q3 · %

Exact inputs and evidence
  • Operating Income: -21956000 USD Source
  • Revenue: 9098000 USD Source

Operating cash flow

-22.5 million USD

2026 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -103000000 USD Source
  • Operating Cash Flow: -80549000 USD Source
Cash and cash equivalents
46.9 million USD Source
Exact value

46851000 USD

Long-term debt including current maturities
4.06 million USD
Exact inputs and evidence

4061000 USD

  • Long-term debt including current maturities: 4061000 USD Source
Shares outstanding
16.6 million shares Source
Exact value

16598678 shares

Reported share-count change

-80.50% · -68.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 85101749 shares · 2025-09-30· Source
  • 16598678 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

45.1 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Revenue: 102484000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 90837000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 14523000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 9839000 USD · 2026-04-01 – 2026-06-30 Source
  • Revenue: 9098000 USD · 2026-07-01 – 2026-09-30 Source

Net income

-155 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: -191086000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -144324000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -38484000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -38533000 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: -31489000 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-129 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -177231000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -150796000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -42259000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -80549000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -42259000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -103000000 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -80549000 USD · 2026-01-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-12.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 10 of 11 periods available· newest 2025-12-31
  • Operating income: 10 of 11 periods available· newest 2025-12-31
  • Net income: 10 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 10 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2018-12-31
  • Total assets: 9 of 11 periods available· newest 2025-12-31
  • Total liabilities: 9 of 11 periods available· newest 2025-12-31
  • Current assets: 9 of 11 periods available· newest 2025-12-31
  • Current liabilities: 9 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 10 of 11 periods available· newest 2025-12-31
  • Long-term debt including current maturities: 5 of 11 periods available· newest 2023-12-31
  • Shares outstanding: 9 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +65.2%

    Prior period

    USD 62.04 million

    –

    Current period

    USD 102.48 million

    –

    Exact inputs and evidence

    102484000 − 62043000 = 40441000 USD

    62043000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    102484000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 36.38 million

    Prior period

    −USD 227.46 million

    –

    Current period

    −USD 191.09 million

    –

    Exact inputs and evidence

    -191086000 − -227461000 = 36375000 USD

    -227461000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -191086000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 14.31 million

    Prior period

    −USD 191.54 million

    –

    Current period

    −USD 177.23 million

    –

    Exact inputs and evidence

    -177231000 − -191540000 = 14309000 USD

    -191540000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -177231000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 102.48 million 100% of revenue
  • Operating costs Derived USD 260.85 million 255% of revenue
  • Operating income −USD 158.37 million −155% of revenue
  • Tax, interest and other Derived USD 32.72 million 32% of revenue
  • Net income −USD 191.09 million −186% of revenue

Cash

  • Operating cash flow −USD 177.23 million −173% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2016 Net income was higher than operating income, so the split is not drawn.
  • 2017 Operating loss: operating costs were 137% of revenue.
  • 2018 Operating loss: operating costs were 197% of revenue.
  • 2019 Operating loss: operating costs were 230% of revenue.
  • 2020 Operating loss: operating costs were 266% of revenue.
  • 2021 Operating loss: operating costs were 259% of revenue.
  • 2022 Operating loss: operating costs were 290% of revenue.
  • 2023 Operating loss: operating costs were 158% of revenue.
  • 2024 Operating loss: operating costs were 484% of revenue.
  • 2025 Operating loss: operating costs were 255% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2016 2016-01-01 – 2016-12-3159731000 58367000 Derived 1364000 -338000 Derived 1702000 -17547000 Derived
Source
2017 2017-01-01 – 2017-12-3151741000 71013000 Derived -19272000 416000 Derived -19688000 -40389000 Derived
Source
2018 2018-01-01 – 2018-12-3138419000 75642000 Derived -37223000 -1906000 Derived -35317000 11126000 Derived
Source
2019 2019-01-01 – 2019-12-3142736000 98204000 Derived -55468000 63736000 Derived -119204000 Unavailable
Source
2020 2020-01-01 – 2020-12-3142722000 113779000 Derived -71057000 -38929000 Derived -32128000 Unavailable
Source
2021 2021-01-01 – 2021-12-3161880000 160404000 Derived -98524000 7014000 Derived -105538000 Unavailable
Source
2022 2022-01-01 – 2022-12-3167772000 196715000 Derived -128943000 -9739000 Derived -119204000 Unavailable
Source
2023 2023-01-01 – 2023-12-31153731000 243009000 Derived -89278000 17515000 Derived -106793000 Unavailable
Source
2024 2024-01-01 – 2024-12-3162043000 300496000 Derived -238453000 -10992000 Derived -227461000 Unavailable
Source
2025 2025-01-01 – 2025-12-31102484000 260851000 Derived -158367000 32719000 Derived -191086000 Unavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 102.5M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.166.0M124.5M83.0M41.5M0.0201620212025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Revenue59731000
2017Revenue51741000
2018Revenue38419000
2019Revenue42736000
2020Revenue42722000
2021Revenue61880000
2022Revenue67772000
2023Revenue153731000
2024Revenue62043000
2025Revenue102484000

Revenue growth

Change in revenue from the same financial period one year earlier.

65.2% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.142%88%34%-20%-75%201620212025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2016Year over yearNo prior comparable period
2017Year over year-13.4%
2018Year over year-25.7%
2019Year over year11.2%
2020Year over year-0%
2021Year over year44.8%
2022Year over year9.5%
2023Year over year126.8%
2024Year over year-59.6%
2025Year over year65.2%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -154.5% 2025
Net margin -186.5% 2025
Free cash flow margin 29% 2018
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.62%-58%-178%-298%-417%201620212025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2016Operating margin2.3%
2017Operating margin-37.2%
2018Operating margin-96.9%
2019Operating margin-129.8%
2020Operating margin-166.3%
2021Operating margin-159.2%
2022Operating margin-190.3%
2023Operating margin-58.1%
2024Operating margin-384.3%
2025Operating margin-154.5%
2016Net margin2.8%
2017Net margin-38.1%
2018Net margin-91.9%
2019Net margin-278.9%
2020Net margin-75.2%
2021Net margin-170.6%
2022Net margin-175.9%
2023Net margin-69.5%
2024Net margin-366.6%
2025Net margin-186.5%
2016Free cash flow margin-29.4%
2017Free cash flow margin-78.1%
2018Free cash flow margin29%
2019Free cash flow marginNot reported
2020Free cash flow marginNot reported
2021Free cash flow marginNot reported
2022Free cash flow marginNot reported
2023Free cash flow marginNot reported
2024Free cash flow marginNot reported
2025Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD -177.2M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.29.0M-30.2M-89.4M-148.7M-207.9M201620212025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Operating cash flow-13153000
2017Operating cash flow-37073000
2018Operating cash flow12683000
2019Operating cash flow-65023000
2020Operating cash flow-67802000
2021Operating cash flow-81679000
2022Operating cash flow3549000
2023Operating cash flow-111616000
2024Operating cash flow-191540000
2025Operating cash flow-177231000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 11.1M 2018
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.15.2M307.9K-14.6M-29.6M-44.5M201620212025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Free cash flow-17547000
2017Free cash flow-40389000
2018Free cash flow11126000
2019Free cash flowUnavailable
2020Free cash flowUnavailable
2021Free cash flowUnavailable
2022Free cash flowUnavailable
2023Free cash flowUnavailable
2024Free cash flowUnavailable
2025Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

176.2% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.190%143%95%48%0%2016-12-3120212025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2016-12-31Liabilities / assetsNot reportedNo source recorded
2017Liabilities / assets115.9%
2018Liabilities / assets41.1%
2019Liabilities / assets37.5%
2020Liabilities / assets15.7%
2021Liabilities / assets26%
2022Liabilities / assets46.7%
2023Liabilities / assets68.2%
2024Liabilities / assets88.5%
2025Liabilities / assets176.2%

Current assets to current liabilities

Current assets divided by current liabilities.

2.01× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.13.80×10.35×6.90×3.45×0.00×2016-12-3120212025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2016-12-31Current assets / current liabilitiesNot reportedNo source recorded
2017Current assets / current liabilities0.8×
2018Current assets / current liabilities5.76×
2019Current assets / current liabilities3.9×
2020Current assets / current liabilities12.78×
2021Current assets / current liabilities5.24×
2022Current assets / current liabilities5.31×
2023Current assets / current liabilities4.5×
2024Current assets / current liabilities2.6×
2025Current assets / current liabilities2.01×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2016 2016-01-01 – 2016-12-31
USD 1.7 million
Exact value

Exact value: 1702000 USD

2016-01-01 – 2016-12-31: 1702000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 13.15 million
Exact value

Exact value: -13153000 USD

2016-01-01 – 2016-12-31: -13153000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 4.39 million
Exact value

Exact value: 4394000 USD

2016-01-01 – 2016-12-31: 4394000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 17.55 million
Calculation and evidence

-13153000 − 4394000 USD

Exact free cash flow: -17547000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2017-01-01 – 2017-12-31
−USD 19.69 million
Exact value

Exact value: -19688000 USD

2017-01-01 – 2017-12-31: -19688000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 37.07 million
Exact value

Exact value: -37073000 USD

2017-01-01 – 2017-12-31: -37073000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3.32 million
Exact value

Exact value: 3316000 USD

2017-01-01 – 2017-12-31: 3316000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 40.39 million
Calculation and evidence

-37073000 − 3316000 USD

Exact free cash flow: -40389000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
−USD 35.32 million
Exact value

Exact value: -35317000 USD

2018-01-01 – 2018-12-31: -35317000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 12.68 million
Exact value

Exact value: 12683000 USD

2018-01-01 – 2018-12-31: 12683000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.56 million
Exact value

Exact value: 1557000 USD

2018-01-01 – 2018-12-31: 1557000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 11.13 million
Calculation and evidence

12683000 − 1557000 USD

Exact free cash flow: 11126000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 119.2 million
Exact value

Exact value: -119204000 USD

2019-01-01 – 2019-12-31: -119204000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 65.02 million
Exact value

Exact value: -65023000 USD

2019-01-01 – 2019-12-31: -65023000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2020 2020-01-01 – 2020-12-31
−USD 32.13 million
Exact value

Exact value: -32128000 USD

2020-01-01 – 2020-12-31: -32128000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 67.8 million
Exact value

Exact value: -67802000 USD

2020-01-01 – 2020-12-31: -67802000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2021 2021-01-01 – 2021-12-31
−USD 105.54 million
Exact value

Exact value: -105538000 USD

2021-01-01 – 2021-12-31: -105538000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 81.68 million
Exact value

Exact value: -81679000 USD

2021-01-01 – 2021-12-31: -81679000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2022 2022-01-01 – 2022-12-31
−USD 119.2 million
Exact value

Exact value: -119204000 USD

2022-01-01 – 2022-12-31: -119204000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3.55 million
Exact value

Exact value: 3549000 USD

2022-01-01 – 2022-12-31: 3549000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2023 2023-01-01 – 2023-12-31
−USD 106.79 million
Exact value

Exact value: -106793000 USD

2023-01-01 – 2023-12-31: -106793000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 111.62 million
Exact value

Exact value: -111616000 USD

2023-01-01 – 2023-12-31: -111616000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2024 2024-01-01 – 2024-12-31
−USD 227.46 million
Exact value

Exact value: -227461000 USD

2024-01-01 – 2024-12-31: -227461000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 191.54 million
Exact value

Exact value: -191540000 USD

2024-01-01 – 2024-12-31: -191540000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2025 2025-01-01 – 2025-12-31
−USD 191.09 million
Exact value

Exact value: -191086000 USD

2025-01-01 – 2025-12-31: -191086000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 177.23 million
Exact value

Exact value: -177231000 USD

2025-01-01 – 2025-12-31: -177231000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

51 filings · 2,346 latest values · 2,346 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001382101, 1382101, STRO, edgar:1382101

Also known as Fundamental Applied Biology Inc, SUTRO BIOPHARMA INC, SUTRO BIOPHARMA, INC.